Journal article
Safety and Effectiveness of Rivaroxaban Versus Warfarin Across GFR Levels in Atrial Fibrillation: A Population-Based Study in Australia and Canada
Abstract
Rationale & Objective: The benefit-risk profile of rivaroxaban versus warfarin for atrial fibrillation (AF) in patients with chronic kidney disease is uncertain. We compared rivaroxaban with warfarin across the range of kidney function in adults with AF.
Study Design: Multicenter retrospective cohort.
Authors
Ha JT; Scaria A; Andrade J; Badve SV; Birks P; Bota SE; Campain A; Djurdjev O; Garg AX; Harel Z
Journal
Kidney Medicine, Vol. 5, No. 7,
Publisher
Elsevier
Publication Date
7 2023
DOI
10.1016/j.xkme.2023.100675
ISSN
2590-0595